Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5346)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 7, 2021 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang M, Zhang CY. Diagnostic biomarkers for pancreatic cancer: An update. World J Gastroenterol 2021; 27(45): 7862-7865 [PMID: 34963749 DOI: 10.3748/wjg.v27.i45.7862] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i45/7862.htm |
| Number | Citing Articles |
| 1 |
Sophia G. Kisling, Pranita Atri, Ashu Shah, Jesse L. Cox, Sunandini Sharma, Lynette M. Smith, Dario Ghersi, Surinder K. Batra. A Novel HOXA10-Associated 5-Gene–Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research 2023; 29(18): 3759 doi: 10.1158/1078-0432.CCR-23-0825
|
| 2 |
Yu Chen, Jialun Wang, Qiyuan Guo, Xihan Li, Xiaoping Zou. Identification of MYEOV-Associated Gene Network as a Potential Therapeutic Target in Pancreatic Cancer. Cancers 2022; 14(21): 5439 doi: 10.3390/cancers14215439
|
| 3 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options. World Journal of Gastroenterology 2022; 28(48): 6827-6845 doi: 10.3748/wjg.v28.i48.6827
|
| 4 |
Fatemeh Tajik, Fahimeh Fattahi, Fereshteh Rezagholizadeh, Behnaz Bouzari, Pegah Babaheidarian, Masoud Baghai Wadji, Zahra Madjd. Nuclear overexpression of DNA damage-inducible transcript 4 (DDIT4) is associated with aggressive tumor behavior in patients with pancreatic tumors. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-46484-3
|
| 5 |
Abinaya Elango, Vineeta Debbie Nesam, Padmaja Sukumar, Infancia Lawrence, Arunkumar Radhakrishnan. Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer. Archives of Microbiology 2024; 206(4) doi: 10.1007/s00203-024-03914-8
|
| 6 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression. World Journal of Gastrointestinal Oncology 2022; 14(8): 1456-1468 doi: 10.4251/wjgo.v14.i8.1456
|
| 7 |
Qian Zhao, Yan Wang, Tianyu Huo, Furong Li, Lu Zhou, Yongliang Feng, Zhigang Wei. Exploration of Risk Factors for Pancreatic Cancer and Development of a Clinical High-Risk Group Rating Scale. Journal of Clinical Medicine 2023; 12(1): 358 doi: 10.3390/jcm12010358
|
| 8 |
Luoluo Wang, Shuping Zhou, Yi Ruan, Xiang Wu, Xueming Zhang, Yi Li, Dongjian Ying, Yeting Lu, Yuan Tian, Gong Cheng, Jing Zhang, Kaiji Lv, Xinhua Zhou. Hypoxia-Challenged Pancreatic Adenocarcinoma Cell-Derived Exosomal circR3HCC1L Drives Tumor Growth Via Upregulating PKM2 Through Sequestering miR-873-5p. Molecular Biotechnology 2024; doi: 10.1007/s12033-024-01091-z
|